drugset / Trial / NCT05398757

Propofol and Dexmedetomidin vs Midazolam Intraoperative Sedation and POCD

NCT05398757 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

This study will examine the effect of intraoperative sedation with midazolam, propofol and dexemdetomidine on the occurrence of postoperative cognitive impairment in patients undergoing surgical treatment of pertrochanteric fracture of the femur.

Timeline

Start
2022-07-01
Primary completion
2024-03-01
Completion
2024-03-01

Outcome

Outcome not reported

Stopped (Enrollment): “Too long recruitment period due to small number of patients”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Subject Midazolam Small molecule 0.05 mg/kg Intravenous
Subject Midazolam Small molecule 0.07 mg/kg Intravenous
Comparator Propofol Small molecule 25 ug/kg Intravenous
Comparator Propofol Small molecule 27 ug/kg Intravenous

Indications

No indication recorded.